Source: International Congress 2018 – Latest developments in cystic fibrosis
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Glasgow (Dublin, Ireland), S. Vencken (Dublin, Ireland), C. De Santi (Dublin, Ireland), R. Raoof (Dublin, Ireland), D. Henshall (Dublin, Ireland), B. Linnane (Limerick, Ireland), P. Mcnally (Dublin, Ireland), C. Greene (Dublin, Ireland). The TLR4 regulator miR-21 is downregulated in the paediatric cystic fibrosis airway. 3420

Member's Comments

No comment yet.

Related content which might interest you: miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production Source: Eur Respir J 2015; 46: 1350-1360 Year: 2015 TLR-4 expression is reduced in cystic fibrosis bronchial epithelial cells Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium Source: Eur Respir J 2013; 41: 1315-1323 Year: 2013 Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients Source: Eur Respir J 2014; 44: 802-805 Year: 2014 Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 180-189 Year: 2001 Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 37: 79-87 Year: 2011 Wnt-inducible protein (WISP-1) is a key regulator of alveolar epithelial cell hyperplasia in pulmonary fibrosis Source: Eur Respir Rev 2006; 15: 180-181 Year: 2006 Wnt-inducible protein (WISP-1) is a key regulator of alveolar epithelial cell hyperplasia in pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 147s Year: 2006 Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 MiRNA expression profile is altered upon cystic fibrosis pulmonary exacerbation Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Cross-talk of inflammatory mediators and airway epithelium reveals the cystic fibrosis transmembrane conductance regulator as a major target Source: ERJ Open Res, 7 (4) 00247-2021; 10.1183/23120541.00247-2021 Year: 2021 Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction Source: Eur Respir J 2004; 23: 846-850 Year: 2004 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 The lung epithelium is a prominent source of Wnt ligands and inhibitors in idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Comparative expression of SPLUNC1 and LPLUNC1 in normal and cystic fibrosis lung Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 A three miRNA signature regulates the CF transmembrane conductance regulator (CFTR) in cystic fibrosis airway epithelium Source: Annual Congress 2011 - Epithelial cells: role in health and disease Year: 2011 Do characteristic airway epithelial change precede the development of lung fibrosis? Ectopic epithelial marker protein expression in bleomycin induced fibrosis replicates that seen in bronchiolized epithelium in IPF Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 SRC family kinase inhibition reduces NOX4 expression in bronchial epithelial cells from Idiopathic Pulmonary Fibrosis patients Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019